Black Friday Deal: $15 OFF Forever on All Plans — Limited Time Only!
ABMD logo
NASDAQ · ABMDMedical - DevicesUpdated Not supplied

Abiomed, Inc. P/E ratio

Current valuation, historical context, and peer comparisons.

Current P/E ratio

65.36×

17.1% belowthe 10-year annual average

Share price381.02
÷
Earnings per share5.83

Price and EPS in quote currency. Calculation details

Investors are paying 65.36 for every 1 of reported earnings per share.

P/E over time

2013 – 2022
Annual P/ESelected-period average 78.88×
3-year average68.83×3 positive annual observations
5-year average73.84×5 positive annual observations
10-year average78.88×10 positive annual observations
Peer median · TTM41.38×7 peers with positive P/E

Historical P/E ratios

Annual period-end data · 25 observations

ABMD annual P/E history, newest first
Period endP/EChange
Mar 31, 2022110.41×+73.2%
Mar 31, 202163.75×+97.2%
Mar 31, 202032.33×-32.8%
Mar 31, 201948.14×-58.0%
Mar 31, 2018114.56×+10.7%
Mar 31, 2017103.47×-1.8%
Mar 31, 2016105.34×+312.1%
Mar 31, 201525.56×-81.3%
View all 25 annual observations +
ABMD annual P/E history, newest first
Period endP/EChange
Mar 31, 2014137.05×+184.6%
Mar 31, 201348.16×-91.3%
Mar 31, 2012554.75×N/M
Mar 31, 2011N/MN/M
Mar 31, 2010N/MN/M
Mar 31, 2009N/MN/M
Mar 31, 2008N/MN/M
Mar 31, 2007N/MN/M
Mar 31, 2006N/MN/M
Mar 31, 2005N/MN/M
Mar 31, 2004N/MN/M
Mar 31, 2003N/MN/M
Mar 31, 2002N/MN/M
Mar 31, 2001N/MN/M
Mar 31, 2000N/MN/M
Mar 31, 1999N/MN/M
Mar 31, 1998N/MN/M

Change is relative to the preceding observation. N/M values are excluded from averages.

How ABMD compares

Company P/E vs. peer trailing-12-month ratios

P/E comparison with ABMD and provider-selected peers
CompanyP/E ratio
ABMD logo
ABMD This stockAbiomed, Inc.
65.36×
SWAV logo
SWAVShockWave Medical, Inc.
83.48×
NUVA logo
NUVANuVasive, Inc.
50.96×
DWRKF logo
DWRKFDrägerwerk AG & Co. KGaA
12.94×
NHNKF logo
NHNKFNihon Kohden Corporation
20.51×
NTUS logo
NTUSNatus Medical Incorporated
84.51×
CSSPF logo
CSSPFNIOX Group Plc
35.93×
EKDHF logo
EKDHFEKF Diagnostics Holdings plc
41.38×
CKMTF logo
CKMTFCarmat S.A.
N/M

Peers are selected by the data provider. Business models and earnings definitions can differ.

Put the numbers in context

What does ABMD’s P/E tell you?

01

Start with its own history

At 65.36×, ABMD is 17.1% below its 10-observation annual average. A lower multiple can reflect a lower price, higher earnings, or weaker growth expectations—not necessarily a bargain.

02

Compare like with like

The median of the 7 positive peer ratios above is 41.38×. Check growth, margins, debt, and earnings quality before interpreting the gap. A faster-growing business may justify a higher multiple.

03

Check what drives earnings

One-off gains can temporarily lower P/E; unusual charges can raise it. Reported earnings and forward estimates answer different questions. Pair this view with return on equity and liquidity for a fuller picture.

Keep your research connected

Take ABMD into your spreadsheet

Pull historical P/E into Excel or Google Sheets with Wisesheets. Build your own comparisons alongside the rest of your financial model.

Explore Wisesheets
Quarterly P/E · latest quarter
=WISE("ABMD", "PE Ratio", "LQ")
LQ selects the latest reported quarter. Requires the Wisesheets add-in. See available data

Sources & calculation methodology

Current P/E

Share price 381.02 ÷ EPS 5.83 = 65.36×. Data is supplied by Financial Modeling Prep through Wisesheets. Quote feed updated Not supplied; this is not a real-time trading quote.

History & averages

Annual and quarterly P/E observations are provided separately from the current quote. Averages use the latest 3, 5, or 10 annual observations, excluding missing and nonpositive ratios. Pre-IPO observations are omitted. These are period-end observations, not daily averages.

Data definitions and limitations

The current quote feed does not specify the exact EPS filing-period end or whether EPS is basic or diluted. We do not label it as forward P/E. Peer ratios are explicitly trailing-12-month (TTM) values. Historical observations do not include independently verified price and EPS inputs. Sources may update on different schedules; rounded inputs can produce small calculation differences. Historical comparisons describe past pricing, not an estimate of fair value.

ABMD P/E ratio: common questions

The essentials behind the numbers.

Abiomed, Inc.'s current P/E is 65.36× based on the quote data last updated Not supplied. It represents the share price divided by reported earnings per share. Prices and earnings may refresh on different schedules.
Annual P/E uses earnings for a completed fiscal year. Trailing-12-month (TTM) P/E uses the latest four quarters, while forward P/E uses forecast earnings. These are not interchangeable. This page labels peer ratios as TTM and shows dated annual or quarterly historical observations; it does not show forward estimates.
N/M means not meaningful: the feed has no positive P/E for that observation. Negative or zero earnings should not be ranked as a low positive valuation multiple. N/M observations are excluded from the averages shown above.
Divide the share price by earnings per share (EPS). For example, a share price of 100 and EPS of 5 gives a P/E of 20×. This page uses the price and EPS supplied together in the quote when both are positive.
Price timestamps, EPS definitions, share classes, adjustments, and fiscal periods can differ. A forward P/E also uses forecast earnings rather than reported earnings. Compare the inputs and as-of dates before comparing two displayed ratios.
Not necessarily. The average describes previous market pricing, not fair value. Changes in earnings quality, growth expectations, debt, accounting, and business risk can justify a different multiple today.